Former president of NARAL Pro–Choice America and New America senior fellow, Ilyse Hogue, spoke with Kettering chief external affairs officer and director of DC operations Brad Rourke about FDA v. Alliance for Hippocratic Medicine. The U.S. Supreme Court could decide to uphold a lower court ruling that bans mifepristone— a drug used in roughly half of all US abortion procedures. Hogue explains why this is important, what is at stake —and what it means for inclusive democracy.